Jepun - Inggeris - すりの適正使用協議会 RAD-AR Council, Japan

towa pharmaceutical co., ltd. - sodium valproate - white tablet, diameter: 10.5 mm, thickness: 6.6 mm

Jepun - Inggeris - すりの適正使用協議会 RAD-AR Council, Japan

sumitomo pharma co.,ltd. - sodium valproate - white tablet (diameter: approx. 8.1mm, thickness: approx. 4.3mm)

Jepun - Inggeris - すりの適正使用協議会 RAD-AR Council, Japan

sumitomo pharma co.,ltd. - sodium valproate - white tablet (diameter: approx. 10.1mm, thickness: approx. 5.2mm)

Jepun - Inggeris - すりの適正使用協議会 RAD-AR Council, Japan

nichi-iko pharmaceutical co.,ltd - sodium valproate - white fine granule

Israel - Inggeris - Ministry of Health

teva medical marketing ltd. - sodium chloride - solution for infusion - sodium chloride 0.9 %w/v - sodium chloride - sodium chloride - treatment of isotonic extracellular dehydration. treatment of sodium depletion. vehicle or diluent of compatible drugs for parenteral administration.

Israel - Inggeris - Ministry of Health

teva medical marketing ltd. - sodium chloride - solution for infusion - sodium chloride 0.9 %w/v - sodium chloride - sodium chloride - treatment of isotonic extracellular dehydration. treatment of sodium depletion. vehicle or diluent of compatible drugs for parenteral administration.

Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

abbvie inc. - valproate sodium (unii: 5vom6gyj0d) (valproic acid - unii:614oi1z5wi) - valproic acid 100 mg in 1 ml - depacon is indicated as an intravenous alternative in patients for whom oral administration of valproate products is temporarily not feasible in the following conditions: depacon is indicated as monotherapy and adjunctive therapy in the treatment of patients with complex partial seizures that occur either in isolation or in association with other types of seizures. depacon is also indicated for use as sole and adjunctive therapy in the treatment of patients with simple and complex absence seizures, and adjunctively in patients with multiple seizure types that include absence seizures. simple absence is defined as very brief clouding of the sensorium or loss of consciousness accompanied by certain generalized epileptic discharges without other detectable clinical signs. complex absence is the term used when other signs are also present. see warnings and precautions (5.1) for statement regarding fatal hepatic dysfunction. because of the risk to the fetus of decreased iq, neurodevelopmental disorders, neural tu

New Zealand - Inggeris - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - sodium valproate 400mg - powder for injection with diluent - 100 mg/ml - active: sodium valproate 400mg excipient: water for injection - epilim iv: the treatment of patients with epilepsy or bipolar disorder, who would normally be maintained on oral sodium valproate, and for whom oral therapy is temporarily not possible.

Malaysia - Inggeris - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

hovid berhad - sodium valproate -

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - sodium valproate -